Mergers & Acquisitions - Mergers & Acquisitions, Inflammatory diseases


Popular Filters

J&J affiliate Cilag GmbH International acquires Covagen

J&J affiliate Cilag GmbH International acquires Covagen


Cilag GmbH International, an affiliate of US health care giant Johnson & Johnson’s Janssen companies,…

Anti-Arthritics/RheumaticsBiotechnologyCilag GmbH InternationalCovagenFynomAbInflammatory diseasesJanssenJohnson & JohnsonMergers & Acquisitions

NicOx to acquire Aciex Therapeutics


Ophthalmology-focused French biotech firm NicOx has entered into an agreement to acquire all of the outstanding…

Aciex TherapeuticsBiotechnologyInflammatory diseasesMergers & AcquisitionsNicOxOphthalmics

Abide Therapeutics in deal with Celgene on immune disorders research


Privately-held Abide Therapeutics has entered into a strategic collaboration with US biotech firm Celgene…

AB101131Abide TherapeuticsBiotechnologyCelgeneImmunologicalsInflammatory diseasesLicensingMergers & Acquisitions

Probiodrug sells its CDK9 inhibitor program to AstraZeneca

Probiodrug sells its CDK9 inhibitor program to AstraZeneca


Privately-held German company Probiodrug says it has transferred its experimental cyclin-dependent kinase…

AstraZenecaInflammatory diseasesMergers & AcquisitionsOncologyPharmaceuticalProbiodrug

Ampio Pharma takes spin-out route on failure to find Zertane partner

Ampio Pharma takes spin-out route on failure to find Zertane partner


US drug developer Ampio Pharmaceuticals announced that it has spun off its sexual dysfunction business…

Ampio PharmaceuticalsAmpionInflammatory diseasesMen's HealthMergers & AcquisitionsPharmaceuticalProductionVyrix PharmaceuticalsZertane

Merck Serono spins out sixth company - Calypso Biotech - to focus on gastrointestinal immunological disorders


German drug major Merck KGaA's (MRK: DE) subsidiary Merck Serono yesterday (March 4) announced the creation…

BiotechnologyCalypso BiotechGastro-intestinalsInflammatory diseasesMerck KGaAMerck SeronoMergers & Acquisitions

Immune Pharmaceuticals to acquire EpiCept under stock merger accord


Privately-held Israeli company Immune Pharmaceuticals and US drug developer EpiCept Corp (Nasdaq: EPCT)…

EpiCeptImmune PharmaceuticalsInflammatory diseasesMergers & AcquisitionsOncologyPharmaceutical

Takeda acquires vaccine maker LigoCyte; signs multi-drug discovery deal with Advinus


Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) says it is to acquire privately-held US vaccine…

Advinus TherapeuticsInflammatory diseasesLicensingLigoCyteMergers & AcquisitionsMetabolicsNeurologicalPharmaceuticalTakeda PharmaceuticalsVaccines

AstraZeneca partners with WuXi AppTec to speed novel biologic to Chinese market


Anglo-Swedish drug major AstraZeneca (LSE: AZN) has formed a joint venture with China's WuXi AppTec to…

Anti-Arthritics/RheumaticsAsia-PacificAstraZenecaBiotechnologyImmunologicalsInflammatory diseasesMEDI5117MedImmuneMergers & AcquisitionsPharmaceuticalResearchWuXi Apptec

Back to top